A compound that offers to give heart attack survivors an improved quality of life has been developed by researchers.
It protects vital tissue that is often destroyed following a heart attack, stroke or major surgery.
Teams from the Medical Research Council and Cambridge University showed that compound MitoSNO worked in mice, the Daily Express reported.
The study has been published in the journal Nature Medicine.
Latest Heart Disease News
The first community-based study, published in the journal Lancet, says that delays in seeking care account for nearly 55% of the reported cardiac and stroke deaths in India.
The study emphasizes the existing proof on the heart disease risks of tobacco smoking and the urgent need to stop smoking among cancer survivors.
New study findings provide novel pathophysiological insights involving blood vessel integrity and tissue-mediated coagulation in a type of heart attack in young women.
Recent study identifies five heart failure subtypes with the potential for individual patient risk prediction.
In middle-age patients, CT scan identifies people who may benefit from drugs to decrease heart disease risk, stated study.